Tricida (NASDAQ:TCDA) is drawing investors' attention as insider trading activity continued to rise in its stock in September. According to TipRanks’ data, the insider confidence signal is positive on TCDA stock. Overall, insiders have bought TCDA stock worth 21.2M in the last three months. What Does Tricida Do?   Tricida is a biopharma company that is focused on the development and commercialization of its drug Veverimer. The investigational drug will treat metabolic acidosis in patients with chronic kidney disease (CKD).
https://www.tipranks.com/news/insider-trading-of-tricida-nasdaqtcda-stock-spike-investors-interest?utm_source=advfn.com&utm_medium=referral
Tricida (NASDAQ:TCDA)
Gráfico Histórico do Ativo
De Out 2022 até Nov 2022 Click aqui para mais gráficos Tricida.
Tricida (NASDAQ:TCDA)
Gráfico Histórico do Ativo
De Nov 2021 até Nov 2022 Click aqui para mais gráficos Tricida.